| ¿µ¹® | hyperthermia, fever | ÇÑ±Û | °í¿ |
|---|---|---|---|
| ¼³¸í | ü¿ÂÁ¶Àý ÁßÃß°¡ ÀÌ»óÀ» ÃÊ·¡ÇØ Ã¼¿ÂÀÌ °è¼Ó »ó½ÂÇÏ¿© Áö¼ÓµÇ°í ÀÖ´Â »óŸ¦ ¸»ÇÑ´Ù. ¿øÀÎÀº ´Ù¾çÇϸç ü¿ÂÁ¶Àý ÁßÃßÀÇ Àå¾Ö(³úÁúȯ), Á¶Á÷Àå¾Ö¿¡ ÀÇÇÑ °ÍÀÌ ÀÖ´Ù. ü¿ÂÀº ÀϹÝÀûÀ¸·Î °Üµå¶ûÀÌ, ÀÔ¾È, °ðâÀÚ¿¡¼ Àç°í, ½Ã°£Àº 10ºÐÀ» ÇÊ¿ä·Î ÇÑ´Ù. Åë»ó 37¡É ÀÌÇÏ(°Üµå¶ûÀÌ)·Î, ÀÔ¾È ¿Âµµ´Â À̺¸´Ù 0.1~0.2¡É ³ôÀ¸¸ç, °ðâÀڿµµ´Â 0.2~0.5¡É ³ô´Ù. °íü¿ÂÁõ¿¡¼µµ µ¿°á°ú À¯»çÇÑ ¼¼Æ÷ º¯È°¡ ³ªÅ¸³´Ù. Áï Ç÷°ü³»ÇǼ¼Æ÷¿¡ ¼Õ»óÀÌ »ý±â°í Ç÷°üÅõ°ú°¡ Áõ°¡µÇ¾î ºÎÁ¾, ¼öÆ÷ µîÀÌ Çü¼ºµÈ´Ù. |
||
| ¿µ¹® | dengue fever | ÇÑ±Û | µ±â |
|---|---|---|---|
| ¼³¸í | ÁÖ·Î ¿´ëÁö¹æ¿¡¼ ¹ß»ýÇÏ´Â ¹ÙÀÌ·¯½º¼º ¿º´. 4~8ÀÏÀÇ Àẹ±â¸¦ °ÅÃÄ ±Þ°ÝÇÏ°Ô ¹ß¿Çϰí, °á¸·ÃæÇ÷-°üÀýÅë-±ÙÀ°Åë-¹éÇ÷±¸°¨¼Ò µîÀÇ Áõ»óÀ» º¸ÀδÙ. ´ëºÎºÐ 7~10ÀÏ ÈÄ¿¡´Â ȸº¹µÇ¸ç, »ç¸ÁÇÏ´Â ¿¹´Â µå¹°´Ù. ¹Ì±¹ÀÇ ¼¼±ÕÇÐÀÚÀÎ C.F. Å©·¹À̱״ 1907³â Çʸ®ÇÉ¿¡¼ µ±â¿Àº ¸ð±â¿¡ ÀÇÇØ °¨¿°µÈ´Ù´Â °ÍÀ» È®ÀÎ-º¸°íÇß´Ù. Á¦2Â÷ ¼¼°è´ëÀü Á÷ÈÄ ¹Ì±¹ÀÇ ¼¼±ÕÇÐÀÚ A. B. ¼¼À̺óÀº ±×ÀÇ ¿¬±¸¿¡ ÀÇÇØ µ±â¿ ¹ÙÀÌ·¯½º¿¡´Â ¸é¿ªÇÐÀûÀ¸·Î ³×°¡Áö ÇüÀÌ ÀÖ´Ù°í ¹àÇû´Ù. µ±â¿ ¹ÙÀÌ·¯½º¸¦ ¸Å°³ÇÏ´Â ¸ð±â¿¡´Â ÀÌÁýÆ®½£¸ð±â(Aedes aegypti)¿Í ÈòÁÙ½£¸ð±â(Aedes albopictus)°¡ ¾Ë·ÁÁ® ÀÖ´Ù. ÀÌ º´¿¡ °É¸®°í ³ª¸é ¸é¿ªÀÌ »ý±âÁö¸¸ Áö¼Ó±â°£Àº ºñ±³Àû ª´Ù. |
||
| ¿µ¹® | typhus fever | ÇÑ±Û | ¹ßÁøÆ¼Çª½º |
|---|---|---|---|
| ¼³¸í | °í¿°ú ¹ßÁøÀÌ ÁÖÁõ¼¼ÀÎ ¿¼º-±Þ¼ºÀÇ ¹ýÁ¤Àü¿°º´. ¼¼°èº¸°Ç±â±¸(WHO)ÀÇ º¸°Ç±ÔÄ¢¿¡ ÀÇÇÑ ±¹Á¦ °¨½Ã Àü¿°º´ÀÇ ÇϳªÀ̱⵵ ÇÏ´Ù. ¶ÇÇÑ, ÀÌ º´ÀÇ À¯ÇàÀº ÀüÀï°ú °ü°è°¡ ±í¾î ÀüÀïÆ¼Çª½º ¶Ç´Â ±â±Ù¿-±³µµ¼Ò¿ µîÀÇ º°¸íÀÌ ÀÖ´Ù. ±×°ÍÀº ÀÌ º´ÀÇ ¸Å°³°ïÃæÀÎ ¡®¿ÊÀÌ¡¯°¡ ÀÇ·ù³ª ¸öÀÌ ´õ·¯¿ï ¶§ ¹ß»ýÇϱ⠽¬¿ì¹Ç·Î ±º´ë³ª ±³µµ¼Ò, ÀüÀïÅÍ µî ȯ°æÀÌ ³ª»Û °÷¿¡¼ Å©°Ô À¯ÇàÇÏ°Ô µÇ¾ú±â ¶§¹®À̾ú´Ù. Á¦1Â÷ ¼¼°è´ëÀü ´ç½Ã ·¯½Ã¾Æ¿¡¼ ¹ß»ýÇÑ È¯ÀÚÀÇ ¼ö´Â 2,500¸¸ ¸íÀ̳ª µÇ¾ú°í, ¿µ±¹°ú ±âŸ À¯·´¿¡¼µµ ÀüÀï-±â±Ù ¶§¹®¿¡ ÀÌ º´ÀÌ ´ëÀ¯ÇàÇß´ø ±â·ÏÀÌ ÀÖÀ¸¸ç, ÀϺ»¿¡¼µµ Á¦2Â÷ ¼¼°è´ëÀü Á÷ÈÄ¿¡ À¯Çà Çß¾ú´Ù. ¿À´Ã³¯¿¡´Â ¾ÆÇÁ¸®Ä«-À¯·´-¾Æ½Ã¾ÆÀÇ ÀϺÎÁö¿ª¿¡¸¸ Á¸ÀçÇÒ »ÓÀÌ´Ù. º´¿øÃ¼´Â ¸®ÄÉÂ÷ ÇÁ·Î¹ÙÁ¦Å°(Rickettsia prowazeki)·Î ¿ÊÀÌ¿¡ ±â»ýÁõ½ÄÇÏ¿© ¿ÊÀÌÀÇ ºÐº¯°ú ÇÔ²² ¹è¼³µÇ¸é¼ ¿ÊÀ̰¡ ÈíÇ÷Çϱâ À§ÇØ ÇǺο¡ ÁØ »óó³ª »ç¶÷ÀÌ ¼ÕÀ¸·Î ±Ü¾î »ý±ä »óó¸¦ ÅëÇÏ¿© °¨¿°µÈ´Ù. Àẹ±â°£Àº 10~14ÀÏÀÌ¸ç ±ÞÀÛ½º·± ¿ÀÇÑÀ̳ª ÇÔ²² ¹ß¿ÇÏ¿© 3ÀÏ Á¤µµ °æ°úµÇ¸é 40¡É ÀüÈÄÀÇ °í¿ÀÌ ³ª°Ô µÇ°í, µÎÅë-°üÀýÅë-°á¸·ÃæÇ÷ µî°ú Áö¸§ 2mm ¾ÈÆÆÀÇ ºÓ°í ÀÛÀº ÃâÇ÷¼º ¹ßÁøÀÌ ¿Â¸ö¿¡ ¸¹ÀÌ »ý±ä´Ù. Áõ¼¼´Â ÀåÆ¼Çª½º¿Í ºñ½ÁÇϰí, ¹ÙÀÏ-Æç¸¯½º¹ÝÀÀ(Weil-Felix test)À̶ó ÇÏ´Â Ç÷û¹ÝÀÀ¿¡ ÀÇÇØ °¨º°µÈ´Ù. Ŭ·Î¶÷Æä´ÏÄÝÀ̳ª Åׯ®¶ó»çÀÌŬ¸°°èÀÇ Ç×»ý¹°ÁúÀÌ Æ¯È¿¸¦ º¸¿© Ä¡»çÀ²µµ ³·¾ÆÁ³´Ù(20%). ¿¹¹æÀ¸·Î´Â »ìÃæÁ¦·Î ¿ÊÀ̸¦ ±¸Á¦ÇÏ´Â °ÍÀÌ °¡Àå Áß¿äÇϸç, ¹ßÁøÆ¼Çª½º¹é½Å Á¢Á¾µµ À¯È¿ÇÏ´Ù. |
||
| ¿µ¹® | scarlet fever | ÇÑ±Û | ¼ºÈ«¿ |
|---|---|---|---|
| ¼³¸í | AÇü¿ëÇ÷»ç½½¾Ë±Õ¿¡ ÀÇÇÑ ¹ýÁ¤ ±Þ¼ºÀü¿°º´ÀÌ´Ù. 5~10¼¼ÀÇ ¼Ò¾Æ¿¡¼ È£¹ßÇÑ´Ù. ÀÛÀº ħ¹æ¿ïÀ» ÅëÇÏ¿© °¨¿°µÇ¸ç Àẹ±âÀÎ 2~4ÀÏÀ» Áö³ª, ÃʱâÁõ»óÀº °í¿, ÀεÎÁ¡¸·, Æíµµ°¡ ÇöÀúÇÏ°Ô ¹ßÀûÁ¾´ëµÈ´Ù. 1~2ÀÏ ÈÄ ºñÀ¶ÇÕ¼ºÀÇ È«»ö¼Ò±¸ÁøÀÌ Àü½Å¿¡ ÃâÇöÇÑ´Ù. ÀÔ ¾ðÀú¸®¿¡´Â ¹ßÁøÀÌ ¾ø°í ÀÔ¼úÁÖÀ§´Â â¹éÇÏ¸ç µþ±âÇô¸¦ º»´Ù. 2~3ÀÏ ÈÄ ¹ßÁøÀÌ »ç¶óÁø´Ù. º´º¯ºÎÀÇ ´ëºÎºÐÀº Ç¥ÃþÀÌ ¹Ú¸®µÇ´Âµ¥ ƯÈ÷ ¼Õ°ú ¹ßÀÇ À¶ÇÕ¼º Å»Çǰ¡ Ư¡ÀÌ´Ù. ÇöÀç´Â °ú°Å¿¡ ºñÇÏ¿© ÈξÀ º´ÀÌ °¡º¿öÁ®¼ ÁßÀÌ¿°, ¹ÙÀ§, ȳó¸²ÇÁÀý¿°µµ µå¹°´Ù. ÀεÎÁ¡¸·¹è¾çÀ¸·Î ±ÕÀ» Áõ¸íÇÏ¿© Áø´ÜÇÑ´Ù. A±º »ç½½¾Ë±Õ°¨¿°ÀÇ ÇÕº´ÁõÀ¸·Î´Â ¸é¿ªº¹ÇÕü¼ºÄáÆÏ¿°°ú ·ù¸¶Æ¼½º¿ÀÌ µÈ´Ù. |
||
| ¿µ¹® | fever | ÇÑ±Û | ¿ |
|---|---|---|---|
| ¼³¸í | ü¿ÂÁ¶Àý ÁßÃß°¡ ÀÌ»óÀ» ÃÊ·¡ÇØ Ã¼¿ÂÀÌ °è¼Ó »ó½ÂÇÏ¿© Áö¼ÓµÇ°í ÀÖ´Â »óŸ¦ ¸»ÇÑ´Ù. ¿øÀÎÀº ´Ù¾çÇϸç ü¿ÂÁ¶Àý ÁßÃß¿¡ Àå¾Ö(³úÁúȯ), Á¶Á÷ Àå¾Ö¿¡ ÀÇÇÑ °ÍÀÌ ÀÖ´Ù. ü¿ÂÀº ÀϹÝÀûÀ¸·Î °Üµå¶ûÀÌ, ÀÔ¾È, °ðâÀÚ¿¡¼ Àç°í, ½Ã°£Àº 10ºÐÀ» ÇÊ¿ä·Î ÇÑ´Ù. Åë»ó 37¡ÉÀÌÇÏ(°Üµå¶ûÀÌ)·Î, ÀÔ¾È ¿Âµµ´Â À̺¸´Ù 0.1~0.2¡É ³ôÀ¸¸ç, °ðâÀڿµµ´Â 0.2~0.5¡É ³ô´Ù. |
||
| HFRS | Hemorrhagic Fever with Renal Syndrome [HP 849-50] = Korean Hemorrhagic Fever &nbs... |
|---|---|
| ABCDES | abnormal alignment, bones-periarticular osteoporosis, cartilage-joint space loss, deformities, margi... |
| YF | yellow fever |
| YFI | yellow fever immunization |
| YFMD | yellow fever membrane disease |
| PEP | Post-exposure prophylaxis |
|---|---|
| YF | Yellow Fever |
| YF | Yellow Fever virus |
| YFV | Yellow Fever virus |
| BYDV | Barley yellow dwarf virus |
| jungle yellow fever | A form occurring in South America, transmitted by Aedes leucocelaenus and various treetop mosquitoes of the Haemagogus complex; transmitted normally to primates, occasionally by chance to man to set off a human outbreak of classical yellow fever transmitted by Aedes aegypti. (05 Mar 2000) |
|---|---|
| yellow fever | <microbiology> An acute febrile illness of tropical regions, caused by a group B arbovirus and spread by a mosquito (Aedes aegypti). Characteristic features include: jaundice, black vomit and the absence of urination. Vaccination is available for travelers to endemic areas. (27 Sep 1997) |
| yellow fever vaccination | A live attenuated (weakened) viral vaccine recommended for people traveling to or living in tropical areas in the americas and africa where yellow fever occurs. (12 Dec 1998) |
| yellow fever vaccine | A living, attenuated strain (17D) of yellow fever virus propagated in embryonated fowl eggs. A suspension of dried mouse brain infected with French neurotropic (Dakar) strain of yellow fever virus, administered topically by the scratch method; not officially recommended in the United States because of meningoencephalitic reactions. (05 Mar 2000) |
| yellow fever virus | <virology> A togavirus (Class IV) with an RNA genome responsible for the disease of the name whose symptoms include fever and haemorrhage. Transmitted by the mosquitoes Aedes aegypti and Haemagogus. Only one antigenic type of the virus known and causes fatal hepatitis in many primates, including humans. This virus is endemic to areas of Africa, South America and the Carribean and has been a major epidemic threat. (11 May 1997) |
| active prophylaxis | Use of an antigenic (immunogenic) agent to actively stimulate the immunological mechanism. (05 Mar 2000) |
| antibiotic prophylaxis | Use of antibiotics before, during, or after a diagnostic, therapeutic, or surgical procedure to prevent infectious complications. (12 Dec 1998) |
| passive prophylaxis | Use of an antiserum from another person or animal to provide temporary (a week to 10 days) protection against a specific infectious or toxic agent. (05 Mar 2000) |
| chemical prophylaxis | The administration of chemicals or drugs to members of a community to reduce the number of carriers of a disease and to prevent others contracting the disease. (05 Mar 2000) |
| CNS prophylaxis | Chemotherapy or radiation therapy to the central nervous system (CNS). This is preventative treatment. It is given to kill cancer cells that may be in the brain and spinal cord, even though no cancer has been detected there. (12 Dec 1998) |
| prophylaxis | The prevention of disease, preventive treatment. Origin: Gr. Prophylassein = to keep guard before (18 Nov 1997) |
| dental prophylaxis | Treatment for the prevention of periodontal diseases or other dental diseases by the cleaning of the teeth in the dental office using the procedures of dental scaling and dental polishing. The treatment may include plaque detection, removal of supra- and subgingival plaque and calculus, application of caries-preventing agents, checking of restorations and prostheses and correcting overhanging margins and proximal contours of restorations, and checking for signs of food impaction. (12 Dec 1998) |
| acridine yellow | A faintly yellow solution with strong bluish-violet fluorescence; used as a topical antiseptic and as a fluorescent stain in histology. Synonym: 5-aminoacridine hydrochloride, 9-aminoacridine hydrochloride. (05 Mar 2000) |
| acute yellow atrophy of the liver | A lesion in which there is extensive and rapid death of parenchymal cells of the liver, sometimes with fatty degeneration of the size of the organ; the necrosis may result from fulminant viral infection or chemical poisoning; associated with jaundice. Synonym: acute parenchymatous hepatitis, Rokitansky's disease. (05 Mar 2000) |
| brilliant yellow | An indicator dye that changes from yellow to orange or red at pH 6.4 to 8.0. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|